Ciprofloxacin EP IMpurity A NEW

$ 44.00 /500mg

Min. Order
Purity99.92%
Cas No86393-33-1
Supply Ability10g
Update time2025-06-18

TargetMol Chemicals Inc.

5YR

United States

Since2011-01-07

Address36 Washington Street, Wellesley Hill, MA

show less show more

Chemical Properties

Product Name	Ciprofloxacin EP IMpurity A
CAS No	86393-33-1
EC-No
Min. Order
Purity	99.92%
Supply Ability	10g
Release date	2025/06/18

Product Introduction

Bioactivity

Name	Ciprofloxacin EP IMpurity A
Description	Ciprofloxacin EP IMpurity A (Fluoroquinolonic Acid) is an antibiotic and antimicrobial agent.
Storage	Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice.
Solubility Information	DMSO : 2.82 mg/mL (10 mM), Sonication is recommended. H2O : Limited solubility
Keywords	Ciprofloxacin EP IMpurity A \| Antibiotic
Inhibitors Related	Neomycin sulfate \| L-Lactic acid \| Ampicillin sodium \| Doxycycline (hyclate) \| Cefaclor monohydrate \| Kanamycin sulfate \| Rifaximin \| Sulfamethoxazole sodium \| Metronidazole \| Doxycycline \| EDTA copper(II) disodium salt \| Sulfachloropyridazine
Related Compound Libraries	Bioactive Compound Library \| NO PAINS Compound Library \| Bioactive Compounds Library Max \| Drug Metabolite/Impurity Library \| Anti-Infection Compound Library

show less show more

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.